Q and A

Question

Is Odimune safe in pregnancy?

I am an HIV positive woman and I am pregnant.

I have just received Odimune but I have a few concerns.

The leaflet which accompanies the batch states that Odimune is not recommended for pregnant women because safety and efficacy has not been established.

Is Odimune safe for pregnant or breastfeeding women?

Answer

Hello,

Thanks for your email. We have a lot of questions from women taking this combination in pregnancy.

Odimune is a generic version of Atripla. This link is to a previous question about use in pregnancy. Atripla contains the same drugs as Odimune, it’s just a different name because it’s made by a different company.

If you have any questions after reading this please let me know and I will be more than happy to help!

55 comments

  1. Simon Collins

    Hi there

    If your partner was was taking HIV treatment then the risk to you is much lower. If their viral load was undetectable, the risk becomes zero. The Odimune might reduce the risk of you don’t know about the viral load. Although it might be okay to use for a month during pregnancy until you get your HIV test results, this drug is not used this way in the UK.

  2. Unknown

    Hi I’m a pregnancy woman n I’m negative then I stay with positive partner then we had condom bust n after some weeks we found out I’m pregnant n I went to clinic they give me odimune so I want know if I’m safe n my pregnancy to get this virus

  3. Lisa Thorley

    Hi Anonymous,

    Yes it’s safe to take acriptega when pregnant.

  4. Anonymous

    Hi
    I am concerned i started to use acriptega and i recently found out that am pregnant will it affect my child.

  5. Lisa Thorley

    Hi Lizzue,

    When someone starts medication, their viral load should ideally become undetectable within 1-3 months of starting medication. Do you know what yours is? For more info about pregnancy and what to expect, please see here: https://i-base.info/guides/pregnancy

Comment

Your email address will not be published. Required fields are marked *